Literature DB >> 10782826

Gene delivery to human chondrocytes by an adeno associated virus vector.

Y Arai1, T Kubo, S Fushiki, O Mazda, H Nakai, Y Iwaki, J Imanishi, Y Hirasawa.   

Abstract

OBJECTIVE: To investigate the efficiency of gene transduction to human chondrocytes using an adeno associated virus (AAV) vector.
METHODS: We transduced green fluorescent protein (GFP) gene using AAV vector to primary human chondrocytes as well as human cartilage organ cultures, in which chondrocytes are surrounded by extracellular matrix. Expression of GFP gene was analyzed at various time points after transduction by fluorescence microscopy and immunohistochemistry.
RESULTS: In primary chondrocytes, the percentages of GFP positive cells were 15.9% or 16.0% on Day 1 and 95.0% or 93.7% on Day 7 after gene transduction. In cartilage organ cultures, gene delivery was observed in cells located not only in the superficial layer but also in the deep layer within the cartilage tissue. Up to 45.3+/-7.4% or 46.0+/-3.9% of chondrocytes expressed GFP for at least 28 days.
CONCLUSION: AAV vector could be useful for direct gene delivery to chondrocytes in situ.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782826

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Effective reduction of the interleukin-1β transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis.

Authors:  K S Santangelo; A L Bertone
Journal:  Osteoarthritis Cartilage       Date:  2011-09-16       Impact factor: 6.576

Review 2.  Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.

Authors:  Ana Rey-Rico; Magali Cucchiarini
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

Review 3.  Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.

Authors:  Magali Cucchiarini; Henning Madry
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

Review 4.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

5.  [Molecular tools to remodel osteoarthritic articular cartilage : growth, transcription, and signaling factors].

Authors:  M Cucchiarini; S Heiligenstein; D Kohn; H Madry
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

Review 6.  Gene therapies for osteoarthritis.

Authors:  Christopher H Evans
Journal:  Curr Rheumatol Rep       Date:  2004-02       Impact factor: 4.592

7.  Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes.

Authors:  Virginie Cottard; Chiara Valvason; Géraldine Falgarone; Didier Lutomski; Marie-Christophe Boissier; Natacha Bessis
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

Review 8.  Orthopedic gene therapy in 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

Review 9.  Clinical potential and challenges of using genetically modified cells for articular cartilage repair.

Authors:  Henning Madry; Magali Cucchiarini
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

10.  Proteoglycan 4 expression protects against the development of osteoarthritis.

Authors:  Merry Z C Ruan; Ayelet Erez; Kilian Guse; Brian Dawson; Terry Bertin; Yuqing Chen; Ming-Ming Jiang; Jason Yustein; Francis Gannon; Brendan H L Lee
Journal:  Sci Transl Med       Date:  2013-03-13       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.